FindTrial
Sign In

A Clinical study comparing two treatment methods for bone healing in patients with Periodontal Bone Loss.

Evaluation Of Recombinant Human Bone Morphogenic Protein (rhbmp-2) Plus Xenograft Versus Xenograft Alone As Compared To Open Flap Debridement In The Treatment of Intrabony Defects - A clinical And Rdiographic Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100876
Enrollment
30
Registered
2026-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 2- Placement

Interventions

Intervention1: Isha Gupta: Participants with intrabony periodontal defects is randomly assigned to three treatment groups. Group I receive open flap debridement alone, where full-thickness flaps eleva

Sponsors

Isha Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: systemically healthy patients having PPD of more than 5mm presence of radiographic evidence of vertical bone loss

Exclusion criteria

Exclusion criteria: patients with any uncontrolled systemic diseases such as diabetes mellitus and hypertension smokers, alcohol abusers

Design outcomes

Primary

MeasureTime frame
to evaluate radiographic bone fill, rate of bone regeneration in all groupsTimepoint: assessed at baseline, 3months and 6 months—

Secondary

MeasureTime frame
to evaluate pocket probing depth, relative attachment levelTimepoint: assessed at baseline,3months and 6 months—

Countries

India

Contacts

Public ContactIsha Gupta

Dasmesh institute of research and dental sciences

dr_preetika_11@yahoo.com9814776744

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026